Data samlet fra 4 kliniske undersøgelser udført over en 20 ugers behandlingsperiode for sår med et overfladeareal mindre end eller lig med 5 cm2, blev 47% af sårene behandlet med becaplermin 100 μg/ g fuldstændig helet, sammenlignet med 35% for de der kun fik placebo gel.
From data combined from 4 clinical trials conducted over a 20 week treatment phase for ulcers of baseline surface area less than or equal to 5 cm2, 47% of ulcers treated with becaplermin 100 µg/ g gel completely healed, compared to 35% which were treated with placebo gel alone.